[HTML][HTML] STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
M Chelvanambi, RJ Fecek, JL Taylor… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background The degree of immune infiltration in tumors, especially CD8+ T cells, greatly
impacts patient disease course and response to interventional immunotherapy. Enhancement …
impacts patient disease course and response to interventional immunotherapy. Enhancement …
Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma
Circulating tumor-derived exosomes (TEX) interact with a variety of cells in cancer-bearing
hosts, leading to cellular reprogramming which promotes disease progression. To study TEX …
hosts, leading to cellular reprogramming which promotes disease progression. To study TEX …
Combined VLA-4–targeted radionuclide therapy and immunotherapy in a mouse model of melanoma
J Choi, W Beaino, RJ Fecek, KPL Fabian… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Very late antigen-4 (VLA-4; also known as integrin α 4 β 1 ) is expressed at high levels in
aggressive and metastatic melanoma tumors and may provide an ideal target for imaging and …
aggressive and metastatic melanoma tumors and may provide an ideal target for imaging and …
CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity
…, SC Watkins, P Kalinski, RJ Fecek… - The Journal of …, 2015 - journals.aai.org
The ability of dendritic cells (DC) to mediate CD4+ T cell help for cellular immunity is guided
by instructive signals received during DC maturation, as well as the resulting pattern of DC …
by instructive signals received during DC maturation, as well as the resulting pattern of DC …
[HTML][HTML] Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint …
…, JL Taylor, M Chelvanambi, RJ Fecek… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Original research: Dendritic cell vaccines targeting tumor blood vessel antigens in
combination with dasatinib induce therapeutic immune responses in patients with checkpoint-…
combination with dasatinib induce therapeutic immune responses in patients with checkpoint-…
Single injection of IL-12 coacervate as an effective therapy against B16-F10 melanoma in mice
Melanoma is the deadliest type of skin cancer with one of the fastest increasing incidence
rates among solid tumors. The use of checkpoint inhibitors (eg αPD-1 antibody) has recently …
rates among solid tumors. The use of checkpoint inhibitors (eg αPD-1 antibody) has recently …
[HTML][HTML] Role of microtubule actin crosslinking factor 1 (MACF1) in bipolar disorder pathophysiology and potential in lithium therapeutic mechanism
D Salem, RJ Fecek - Translational Psychiatry, 2023 - nature.com
Bipolar affective disorder (BPAD) are life-long disorders that account for significant morbidity
in afflicted patients. The etiology of BPAD is complex, combining genetic and environmental …
in afflicted patients. The etiology of BPAD is complex, combining genetic and environmental …
Selective Induction of CTL Helper Rather Than Killer Activity by Natural Epitope Variants Promotes Dendritic Cell–Mediated HIV-1 Dissemination
RB Mailliard, KN Smith, RJ Fecek… - The Journal of …, 2013 - journals.aai.org
The ability of HIV-1 to rapidly accumulate mutations provides the virus with an effective means
of escaping CD8+ CTL responses. In this study, we describe how subtle alterations in CTL …
of escaping CD8+ CTL responses. In this study, we describe how subtle alterations in CTL …
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells
… Mailliard RB, Smith KN, Fecek RJ, Rappocciolo G, Nascimento EJ, Marques ET, Watkins SC,
Mullins JI, Rinaldo CR. 2013. Selective induction of CTL helper rather than … Ronald J. Fecek …
Mullins JI, Rinaldo CR. 2013. Selective induction of CTL helper rather than … Ronald J. Fecek …
[HTML][HTML] Cutaneous melanoma: mutational status and potential links to tertiary lymphoid structure formation
…, M Chelvanambi, WJ Storkus, RJ Fecek - Frontiers in …, 2021 - frontiersin.org
Recent advances in immunotherapy have enabled rapid evolution of novel interventional
approaches designed to reinvigorate and expand patient immune responses against cancer. …
approaches designed to reinvigorate and expand patient immune responses against cancer. …